TITLE

Mammary Endocrine Ductal Carcinoma in Situ: A Case Report

AUTHOR(S)
Danikas, Dimitrios; Averbach M.D., David J.; Matthews, William E.
PUB. DATE
December 2000
SOURCE
American Surgeon;Dec2000, Vol. 66 Issue 12, p1163
SOURCE TYPE
Academic Journal
DOC. TYPE
Case Study
ABSTRACT
Endocrine differentiation represents a pathway of neoplastic development available to a range of breast cancers. This pattern occurs in tumors with different morphological appearances as ductal carcinoma in situ (DCIS), mucinous carcinoma, a variant of lobular carcinoma, and low-grade invasive ductal carcinoma. Endocrine ductal carcinoma in situ is an uncommon entity. It occurs in older women with a mean age of 70 years. Histologically it shows expansile intraductal growth forming solid sheets and festoons transversed by delicate fibrovascular septa. Conventional microscopy permits the diagnosis in most cases. Specialized techniques such as immunohistochemistry and electron microscopy can serve as the basis of diagnosis in the absence of the appropriate morphological features. We present a 68-year-old female with a 1.5-cm firm mobile nodule of the left breast. Mammography and ultrasounds showed a 15 x 15-mm circumscribed solid lobulated nodule. The mass was excised and pathology was positive for endocrine DCIS. Although endocrine DCIS has a biologic marker profile similar to that of well-differentiated or noncomedo DCIS it may constitute a different histogenetic pathway of carcinogenesis in the breast. The tumor may exhibit the invasive characteristics of a neuroendocrine neoplasm. Larger studies and longer follow-up are needed for the determination of the clinical behavior.
ACCESSION #
3918302

 

Related Articles

  • Images in Pathology: Low-grade Intraductal Mammary Carcinoma. Eusebi, Vincenzo // International Journal of Surgical Pathology;Jan2002, Vol. 10 Issue 1, p57 

    Presents photographs depicting the pathology of the intraductal mammary carcinoma.

  • δ-Aminolevulinic acid transport in murine mammary adenocarcinoma cells is mediated by beta transporters. Moretti, M. Bermudez; Garcia, S. Correa; Perotti, C.; Batlle, A.; Casas, A. // British Journal of Cancer;8/12/2002, Vol. 87 Issue 4, p471 

    δ-aminolevulinic acid, the precursor of porphyrin biosynthesis has been used to induce the endogenous synthesis of the photosensitiser protoporphyrin IX for photodynamic therapy in the treatment of various turnouts. The aim of this work was to characterise the δ-aminolevulinic acid...

  • MAMMARY CANCER. Williams, John // Dog World;Jul2003, Vol. 88 Issue 7, p45 

    Discusses the mammary cancer in dogs. Distinguishing traits of the canine mammary tumors; Contributing factors of canine mammary cancer; Types of treatment.

  • Development and characterization of a tamoxifen-resistant breast carcinoma xenograft. Naundorf, H; Becker, M; Lykkesfeldt, A E; Elbe, B; Neumann, C; Büttner, B; Fichtner, I // British Journal of Cancer;6/1/2000, Vol. 82 Issue 11, p1844 

    A human tamoxifen-resistant mammary carcinoma, MaCa 3366/TAM, originating from a sensitive parental xenograft 3366 was successfully established by treatment of tumour-bearing nude mice with 1-50 mg kg[SUP-1] tamoxifen for 3 years during routine passaging. Both tumours did not differ...

  • 312. Human Plasminogen Kringle 5-Engineered Murine Mammary Cancer Cells Arrest Tumor Growth and Promote Long-Term Survival Perri, Sabrina R.; François, Moïra; Galipeau, Jacques // Molecular Therapy;Jun2005, Vol. 11, p121 

    An abstract of the article "Human Plasminogen Kringle 5- Engineered Murine Mammary Cancer Cells Arrest Tumor Growth and Promote Long-Term Survival," by Sabrina R. Perri, Moïra François and Jacques Galipeau is presented.

  • Spectrum of Pheochromocytoma in Multiple Endocrine Neoplasia. Valk, Timothy W.; Frager, Marc S.; Gross, Milton D.; Sisson, James C.; Wieland, Donald M.; Swanson, Dennis P.; Mangner, Thomas J.; Beierwaltes, William H. // Annals of Internal Medicine;Jun81, Vol. 94 Issue 6, p762 

    Presents a study that investigated the spectrum of pheochromocytoma in patients with multiple endocrine neoplasia. Background on multiple endocrine neoplasia; Details on the use of scintigraphy in determining the spectrum of pheochromocytoma in the patients; Results and implications.

  • Carboplatin/paclitaxel.  // Reactions Weekly;10/22/2011, Issue 1374, p13 

    The article describes the case of a 56-year-old man who developed various toxicities after receiving 3-week courses of carboplatin and paclitaxel for recurrent thymic cancer.

  • Multiple endocrine neoplasia type 2. Ponder, Bruce // BMJ: British Medical Journal (International Edition);2/24/90, Vol. 300 Issue 6723, p484 

    Examines the multiple endocrine neoplasia type 2 (MEN 2) in molecular genetics of Great Britain. Relevance in genetic linkage; Progress of the review on MEN 2; Cell development of MEN 2.

  • Endocrinology & metabolism.  // Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS19 

    Presents an abstract of the research manuscript `Assessment of radioactive iodine (RAI) endocrine tumorgenesis - a retrospective study,' by I.B. Rosen from the University of Toronto.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics